Koen Demyttenaere, PhD, MD
- 12Articles
- 39.3KReads
- 2001–2017Active
- 54Collaborators
- 99Citations
About
Koen Demyttenaere, PhD, MD, has published extensively on major depressive disorder, anxiety, and related clinical areas including suicidality, somatoform disorders, and neurology. His work addresses pharmacological treatments such as duloxetine and selective serotonin reuptake inhibitors, as well as patient compliance and treatment resistance in primary care settings. Demyttenaere’s research spans from risk assessment of suicidal thoughts to the evaluation of symptomatic outcomes and medication satisfaction.
Publications
Suicidal Thoughts and Reasons for Living in Hospitalized Patients With Severe Depression: Post-Hoc Analyses of a Double-Blind Randomized Trial of Duloxetine
June 15, 2014
Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials
December 15, 2011
Satisfaction With Medication Is Correlated With Outcome but Not Persistence in Patients Treated With Placebo, Escitalopram, or Serotonin-Norepinephrine Reuptake Inhibitors: A Post Hoc Analysis
July 28, 2011
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
